Table 1.

Untreated patients: Baseline characteristics and demographics

Characteristic	Untreated groupa (N = 30)
Age, y
Mean±SD	8.8±1.8
Min, max	7.0, 13.0
Weight, kg
Mean (SD)	30.6±9.9
Min, max	17.9, 53.2
Standing height, cm
Mean (SD)	122.8±9.0
Min, max	108.0, 142.5
Time since DMD diagnosis at baseline, mo
Mean (SD)	54.7±31.6
Min, max	12.7, 114.9
Corticosteroid treatment, n (%)
Deflazacort	21 (70.0)
Prednisone	9 (30.0)
Corticosteroid schedule, n (%)
Continuous	24 (80.0)
Intermittent	2 (20.0)

Abbreviations: DMD = Duchenne Muscular Dystrophy; SD =standard deviation. ^aIncluded patients with the following mutations: exon 12–44 (n = 1); exon 42–45 (n = 1); exon 43 (n = 1); exon 44 (n = 1); exon 45 (n = 2); exon 45–52 (n = 4); exon 46–47 (n = 3); exon 46–48 (n = 5); exon 46–50 (n = 1); exon 48–52 (n = 2); exon 49–52 (n = 2); exon 51 (n = 2); exon 51–53 (n = 2); exon 51–55 (n = 3).